Hypoadiponectinemia is associated with prehypertension in obese individuals of multiethnic origin

Clinical Cardiology

Volumn 33, Issue 6, 2010, Pages

  Celoria, Bruno M J ^a   Genelhu, Virginia A ^a   Duarte, Stenio Fernando Pimentel ^a   Delfraro, Paula A S ^b   Francischetti, Emilio A ^a  

^a STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b Laboratory of Clinical and Experimental Pathophysiology   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; INSULIN; ADIPOQ PROTEIN, HUMAN; BIOLOGICAL MARKER;

ADULT; ARTICLE; BLOOD PROTEIN DISORDER; BODY MASS; BRAZIL; CONTROLLED STUDY; DISEASE ASSOCIATION; ETHNICITY; HUMAN; HYPERTENSION; HYPOADIPONECTINEMIA; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; OBESITY; PROTEIN BLOOD LEVEL; RADIOIMMUNOASSAY; SYSTOLIC BLOOD PRESSURE; BLOOD; BLOOD PRESSURE; BLOOD PRESSURE MEASUREMENT; CHI SQUARE DISTRIBUTION; CROSS-SECTIONAL STUDY; DEVICES; DOWN REGULATION; EPIDEMIOLOGY; ETHNOLOGY; MIDDLE AGED; PATHOPHYSIOLOGY; RISK; RISK ASSESSMENT; RISK FACTOR; SPHYGMOMANOMETER; STATISTICAL MODEL;

ADIPONECTIN; ADULT; BIOLOGICAL MARKERS; BLOOD PRESSURE; BLOOD PRESSURE DETERMINATION; BODY MASS INDEX; BRAZIL; CHI-SQUARE DISTRIBUTION; CROSS-SECTIONAL STUDIES; DOWN-REGULATION; HUMANS; HYPERTENSION; INSULIN; INSULIN RESISTANCE; LINEAR MODELS; LOGISTIC MODELS; MIDDLE AGED; OBESITY; ODDS RATIO; RADIOIMMUNOASSAY; RISK ASSESSMENT; RISK FACTORS; SPHYGMOMANOMETERS;

EID: 77953837764     PISSN: 01609289     EISSN: 19328737     Source Type: Journal    
DOI: 10.1002/clc.20657     Document Type: Article

References (23)

1. Vasan RS, Larson MG, Leip EP, et al. Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med. 2001;345:1291-1297.
2. Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42:1206-1252.
3. Kshirsagar AV, Carpenter M, Bang H, et al. Blood pressure usually considered normal is associated with an elevated risk of cardiovascular disease. Am J Med. 2006;119:133-141.
4. Sipahi I, Tuzcu EM, Schoenhagen P, et al. Effects of normal, pre-hypertensive, and hypertensive blood pressure levels on progression of coronary atherosclerosis. J Am Coll Cardiol. 2006;48:833-838.
5. Francischetti EA, Genelhu VA. Obesity-hypertension: an ongoing pandemic. Int J Clin Pract. 2007;61:269-280.
6. Chow W-S, Cheung BMY, Tso AWK, et al. Hypoadiponectinemia as a predictor for the development of hypertension: a 5-year prospective study. Hypertension. 2007;49:1455-1461.
7. Berg AH, Combs TP, Scherer PE. ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism. Trends Endocrinol Metab. 2002;13:84-89.
8. Arita Y, Kihara S, Ouchi N, et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun. 1999;257:79-83.
9. Papadopoulos DP, Makris TK, Krespi PG, et al. Adiponectin and resistin plasma levels in healthy individuals with prehypertension. J Clin Hypertens. 2005;7:729-733.
10. Francischetti EA, Celoria BM, Duarte SF, et al. Hypoadiponectinemia is associated with blood pressure increase in obese insulin-resistant individuals. Metabolism. 2007;56:1464-1469.
11. Parra FC, Amado RC, Lambertuci JR, et al. Color and genomic ancestry in Brazilians. PNAS. 2003;100:177-182.
12. Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412-419.
13. Schillaci G, Pirro M. Hypoadiponectinemia: a novel link between obesity and hypertension? Hypertension. 2007;49:1217-1229. (Pubitemid 46809358)
14. Adamczak M, Wiecek A, Funahashi T, et al. Decreased plasma adiponectin concentration in patients with essential hypertension. Am J Hypertens. 2003;16:72-75. (Pubitemid 36078595)
15. Iwashima Y, Katsuya T, Ishikawa K, et al. Hypoadiponectinemia is an independent risk factor for hypertension. Hypertension. 2004;43:1318-1323.
16. Mohlig M, Wegewitz U, Osterhoff M, et al. Insulin decreases human adiponectin plasma levels. Horm Metab Res. 2002;34:655-658. (Pubitemid 36398702)
17. Anderson EA, Hoffman RP, Balon TW, et al. Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans. J Clin Invest. 1991;87:2246-2252.
18. Rahmouni K, Morgan DA, Morgan GA, et al. Hypothalamic P13 kinase and MAP kinase differentially mediate regional sympathoactivation to insulin. J Clin Invest. 2004;114:652-658. (Pubitemid 39578755)
19. DeFronzo RA, Ferrannini E. Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia and atherosclerotic cardiovascular disease. Diabetes Care. 1991;14:173-194.
20. Fasshauer M, Klein J, Neumann S, et al. Adiponectin gene expression is inhibited by beta-adrenergic stimulation via protein kinase A in 3-T3-L1 adipocytes. FEBS Lett. 2001;507: 142-146. (Pubitemid 33001531)
21. Massiera F, Bloch-Faure M, Ceiler D, et al. Adipose angiotensinogen is involved in adipose tissue growth and blood pressure regulation. FASEB J. 2001;15:2727-2729.
22. Niskanen L, Laaksonen DE, Nyyss̈onen K, et al. Inflammation, abdominal obesity, and smoking as predictors of hypertension. Hypertension. 2004;44:859-865. (Pubitemid 39577412)
23. Najjar SS, Scuteri A, Shetty V, et al. Pulse wave velocity is an independent predictor of the longitudinal increase in systolic blood pressure and of incident hypertension in the Baltimore Longitudinal Study of Aging. J Am Coll Cardiol. 2008;51:1377-1383. (Pubitemid 351443076)